Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
Clinical trial NCT06651593 · RECRUITING
Trial details
- NCT number
- NCT06651593
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2028-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.